Venture Life Group PLC
LSE:VLG

Watchlist Manager
Venture Life Group PLC Logo
Venture Life Group PLC
LSE:VLG
Watchlist
Price: 61.5 GBX Market Closed
Market Cap: 78.6m GBX

Venture Life Group PLC
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Venture Life Group PLC
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Venture Life Group PLC
LSE:VLG
Operating Income
ÂŁ2.6m
CAGR 3-Years
-4%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Unilever PLC
LSE:ULVR
Operating Income
€10.9B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
4%
PZ Cussons PLC
LSE:PZC
Operating Income
ÂŁ47.8m
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-8%
Science in Sport PLC
LSE:SIS
Operating Income
-ÂŁ3.6m
CAGR 3-Years
12%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Warpaint London PLC
LSE:W7L
Operating Income
ÂŁ20.8m
CAGR 3-Years
51%
CAGR 5-Years
90%
CAGR 10-Years
N/A
HALEON PLC
LSE:HLN
Operating Income
ÂŁ2.5B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Venture Life Group PLC
Glance View

Market Cap
78.7m GBX
Industry
Consumer products

Venture Life Group Plc engages in the development, manufacture, and commercializing of products for the aging population. The company is headquartered in Bracknell, Berkshire and currently employs 119 full-time employees. The company went IPO on 2014-03-28. The firm is focused on developing, manufacturing and commercializing products for the global self-care market. The firm's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

VLG Intrinsic Value
127.04 GBX
Undervaluation 52%
Intrinsic Value
Price

See Also

What is Venture Life Group PLC's Operating Income?
Operating Income
2.6m GBP

Based on the financial report for Jun 30, 2025, Venture Life Group PLC's Operating Income amounts to 2.6m GBP.

What is Venture Life Group PLC's Operating Income growth rate?
Operating Income CAGR 5Y
-8%

Over the last year, the Operating Income growth was 7%. The average annual Operating Income growth rates for Venture Life Group PLC have been -4% over the past three years , -8% over the past five years .

Back to Top